Tenax Therapeutics, Inc.
TENXNasdaqCIK 34956HealthcareFiscal year ends Dec 31
Reports and events: 321 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0816:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-417939 |
| 2026-09-0908:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-385910 |
| 2026-08-1007:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-341236 |
| 2026-07-3116:15 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-328603 |
| 2026-07-3111:25 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-327455 |
| 2026-07-3107:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-326784 |
| 2026-07-0208:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-293485 |
| 2026-06-3016:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-290661 |
| 2026-06-2916:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-288600 |
| 2026-06-0416:10 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-257400 |
| 2026-05-1216:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-219383 |
| 2026-05-1208:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-218224 |
| 2026-04-2208:17 ET | DEF 14A | Proxy statementPeriod 2026-04-17 | 0001193125-26-168580 |
| 2026-04-2208:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-168521 |
| 2026-03-1018:02 ET | SCHEDULE 13D | Ownership report, active investor | 0001654954-26-002112 |
| 2026-03-1007:48 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-099393 |
| 2026-03-1007:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-002072 |
| 2026-01-0916:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-26-000232 |
| 2025-12-1717:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-014059 |
| 2025-11-1216:40 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-277793 |
| 2025-11-1216:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-25-012921 |
| 2025-09-1608:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-010792 |
| 2025-09-0908:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001654954-25-010510 |
| 2025-08-1316:22 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-108063 |
| 2025-08-1316:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-25-009510 |
| 2025-06-1716:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001654954-25-007104 |
| 2025-05-1416:12 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-071395 |
| 2025-05-1416:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-071382 |
| 2025-04-2507:42 ET | DEF 14A | Proxy statementPeriod 2025-04-24 | 0000950170-25-058329 |
| 2025-03-2516:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-044398 |
| 2025-03-2516:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-044375 |
| 2025-03-0617:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-25-002385 |
| 2024-12-0417:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-24-015161 |
| 2024-11-1316:04 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001654954-24-014262 |
| 2024-11-1308:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-014203 |
| 2024-10-3016:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001654954-24-013505 |
| 2024-09-2708:14 ET | DEF 14A | Proxy statementPeriod 2024-10-25 | 0001654954-24-012375 |
| 2024-08-1316:45 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001654954-24-010456 |
| 2024-08-1316:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-010454 |
| 2024-08-1208:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-24-010278 |
| 2024-08-0607:23 ET | 8-K | 9.01 Financial statements and exhibits | 0001654954-24-009988 |
| 2024-06-1316:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001654954-24-007727 |
| 2024-05-1416:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001654954-24-006228 |
| 2024-05-1409:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-006131 |
| 2024-04-2608:30 ET | DEF 14A | Proxy statementPeriod 2024-06-07 | 0001654954-24-005065 |
| 2024-03-2814:02 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001654954-24-003827 |
| 2024-03-2808:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-003775 |
| 2024-02-2316:30 ET | 8-K | 8.01 Other events | 0001654954-24-002134 |
| 2024-02-2008:33 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001654954-24-001923 |
| 2024-02-1216:46 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-24-001591 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 17:29 ET. Listed shows no prices and gives no investment advice.